of the five long-term survivals, two of whom at 25 and 27 years after treatment, have been seen recently and are all in good health (Fig 2) . Deaths Eight patients died, in 4 of whom there was intracranial extension of the tumour. It is now thought that 4 of the early deaths could have been due to cerebral necrosis caused by high-dose radiation (A W Jackson, personal communication 1973) . Summary In a large oncological centre, only 48 cases of glomus jugulare tumour were seen over nearly thirty years . This is less than two cases each year and it took considerable time to build up knowledge about the different clinical presentations of the tumours and learn about their behaviour and response to different forms of treatment. More tumours arose within the tympanic cavity than in the jugular bulb. From the experience gained in this study, these tumours grow slowly, usually behave in a benign manner and there was only one that metastasized. They produce a varying amount of destruction within the temporal bone and may occasionally extend intracranially, usually into the posterior fossa (four cases). The tumour is potentially dangerous because of its site of origin, but is rarely fatal. Recurrence does sometimes take place, particularly after inadequate removal.
All patients except one complained of aural symptoms and presented initially to an otologist. It is at this stage that a clinical diagnosis should be made and intratympanic tumours should not be missed. With a careful history and examination, including Zeiss microscopy, this should always be possible. In recent years, patients are referred earlier and more tumours are diagnosed at the intratympanic stage. It is possible, at an early stage, by a tympanotomy approach, to excise the encapsulated tumour from the medial wall of the middle ear. The bleeding is brisk only when the tumour is detached from the promontory and can be controlled by coagulation diathermy.
Only one of the patients presented initially to a neurosurgeon and that was because of facial pain and diplopia. Twelve patients (25 %) showed evidence of neurological involvement.
Radiological investigations are invaluable in helping to confirm a clinical diagnosis and can be of further aid in deciding the method of treatment.
In this group, patients were treated by surgery alone or surgery followed by X-ray therapy; progress was usually satisfactory with low morbidity. Radical X-ray treatment is believed to have a growth-restraint action on this slowly growing tumour. Rosenwasser H (1945) Glomus jugulare tumours are extremely rare, accounting for approximately 0.03 % of all malignancies registered at Christie Hospital. Because of their rarity it is difficult for any one centre to collect sufficient cases to assess different methods of treatment. All published series from single centres have been small but reviews of large numbers of cases collected from the world literature have been published by Schermer et al. (1966) and . Bradshaw (1961) published a series from Christie Hospital and Holt Radium Institute covering 1943-1959 in which time sixteen patients were registered. This series increased to thirty-two patients by 1968.
Anatomy
The site of origin of the glomus jugulare tumour has been clearly established following the first descriptions of structures resembling carotid bodies near the jugular bulb. Credit for the discovery of these structures has been variously attributed to Valentin (1840) and Krause (1878) , until Guild (1941) named them as the glomus jugulare. The glomera can occur at different sites within the ear. Guild described their 'Formerly at Christie Hospital and Holt Radium Institute, Manchester occurrence in the adventitia of the dome of the jugular bulb where they are situated with almost equal frequency along Jacobsen's nerve and the auricular branch of the vagus nerve. About a quarter of the structures are located in the mucosa over the cochlear promontory along the tympanic plexus of Jacobsen's nerve. Other glomera occur in the osseous canal which carries the nerve from the jugular fossa to the middle ear.
The glomus jugulare tumour arises from the structures described above and produces its effects by expansion and destruction of the tissues around the site of origin. The natural history of the disease may be extremely long and metastases are extremely rare.
Clinical Details
In 1943-1968, 32 cases were registered at Christie Hospital. Of these, 26 were female and 6 male. The age range on registration varied from 29-78 years, mean 55. The side of the lesion was equally divided: 16 right, 16 left.
A proportion of the patients had received surgical treatment of varying extent before being referred for radiotherapy and presenting symptoms were not always recorded. The following symptoms and signs occurred in 30 patients at any time before radiotherapy: deafness (16 patients), tinnitus (10), discharge (9), bleeding (8), vertigo (6), 'polyps' (4), swelling (2), blockage (1), chronic infection (1), nerve palsiescranial VII only (3), mixed lower cranial nerves (9).
In 25 patients the diagnosis was confirmed histologically but in the remaining 7 patients no biopsy was carried out because of either absence of a visible tumour or decrepitude of the individual. In the unbiopsied cases the diagnosis was made on the history, and on clinical and radiological findings.
Treatment andPrognosis
It is difficult to make an accurate assessment of the value oftreatment in glomusjugulare tumours. The main difficulty occurs because the natural history of the disease is often very long, reaching thirty years on occasions. The time at which treatment is given in this long span of years is dependent on the presence of troublesome symptoms which may appear many years before the patient requests attention. The application of conventional techniques to assess treatment results, i.e. five or ten-year survival figures, is of little value. It is more important to study the regression of tumours after treatment and to record the duration of this regression or arrest of growth. Glomus jugulare tumours often respond extremely slowly to radiotherapy and it is wrong to be pessimistic in the face of no apparent response, one or two months after treatment.
Long-term improvement with complete regression may occur or growth control may be achieved with little change in visible tumour but with relief of symptoms. Because of the site of origin of this tumour the assessment of post-treatment changes may be impossible. Inspection is of no value in cases where the external auditory meatus becomes completely occluded or where a visible tumour has never been present. Petrous tomography may also be of little help in assessing post-treatment changes since bone defects are not always replaced following tumour regression. Similarly, apparently advancing disease on subsequent tomography is not always incompatible with long-term survival without clinical evidence of tumour recurrence. classified cases into a system of staging based on presenting signs and symptoms and radiological findings. In a retrospective study of previously published cases they decided that the choice of treatment should depend on the extent ofdisease, employing radical surgery in the early case and radiotherapy alone in the late case. Schermer et al. (1966) , using a simpler form of staging, also concluded that surgery is the best treatment in the smaller lesions and is probably also indicated in the extensive tumour since 'it offers the only hope for cure'. In both systems of staging the 'early' cases showed no radiological evidence of bone destruction. Our series apparently differs from those reported since we rarely see patients without bone erosion in the vicinity of the tumour. Of twenty-seven patients having baseline petrous tomography only two patients showed no definite evidence of bone destruction. On these occasions the reports read 'slight clouding of the petrous temporal bone' and 'slight disparity of the size of the jugular foramina'. The remaining patients all showed extensive bone destruction. It is obviously important that diagnostic radiological techniques should be of the highest quality to detect small degrees of bone erosion and, unless such methods are used, even moderate degrees of destruction may pass undetected.
Results
It is difficult to obtain figures for comparison from other series. The collected series results of and Schermer et al. (1966) are shown in Tables 1 and 2 respectively. These two series have a large proportion of their cases in common and the two systems of retrospective staging are rather different. The chief criticism must, however, be that the follow-up Table 1 Results of radiotherapy treatment from period reported is too short to give any indication of the value of a selected treatment. The conclusions drawn by these authors are open to doubt and a five-year follow up at least is essential before any treatment method can be recommended. Enthusiasm for surgery as the first treatment in other series is probably due to the difficulty in demonstrating recurrent or residual tumour early after surgical excision. Inspection of a radiated volume is usually easily carried out and may continue to show residual tumour for some time after treatment. The surgeon, however, may be misled that excision has been complete unless follow up is continued sufficiently long to allow recurrence to appear in the depths of the excised volume. In our series, of the 15 patients receiving initial surgery (polypectomy or a more extensive procedure), 12 patients had sujbsequent radiotherapy either immediately postoperatively or on recurrence of tumour. Of the 3 remaining patients, 2 were followed up elsewhere, and 1 refused radiotherapy. Conversely, of 14 patients receiving initial radiotherapy, none had subse-quent surgery despite a joint ENT/radiotherapy follow up in many cases.
The results of treatment are summarized in Table 3 . In addition to crude survival figures, an assessment has been made of the primary control, i.e. freedom from recurrence of the primary tumour at death or last follow-up appointment. This latter figure represents the best result that can be achieved by treatment in the absence of distant metastases or intercurrent death.
In those patients receiving radiotherapy as first treatment, the poor survival is largely due to the death of four patients from possible cerebral necrosis caused by high dose radiation. These all occurred in the early part of the series (Cases 1, 3, 4 and 5). The diagnosis of cerebral damage was only confirmed at post mortem in one patient but it is interesting that this type of complication has not been seen since the volumes irradiated have become more strictly controlled and lower doses have been given. The patients treated more recently by megavoltage show a greatly improved prognosis. Of 6 patients at present unavailable for 5-year survival figures, 4 are alive with residual disease 2-4 years after treatment; one patient is well at three years and one patient died at one year with residual disease. Only one more cerebral complication has been seen, but this is attributable to a carotid angiogram carried out at one year after treatment in an attempt to demonstrate residual tumour; hemiparesis de- veloped. Following radiotherapy symptomatic relief is good although nerve palsies do not usually improve. One patient, however, showed improvement of VII nerve palsy. Bleeding and discharge are often controlled and visible swellings may disappear rapidly or more slowly.
Treatment Technique
In the first few patients treated by radiotherapy in Manchester, orthovoltage techniques were used and high doses were given. Since it is difficult to control accurately the high-dose volume using orthovoltage radiation, considerable dose may be received by the midbrain and other vital structures surrounding the apex of the petrous bone. As has been shown earlier this may cause fatal brain damage. Gaining from this experience in later years, treatment has always been given by megavoltage where the high-dose volume can be arranged to conform almost exactly to the shape of the petrous-temporal bone, thus sparing surrounding tissues. Doses given were reduced to 4500 rad in 21 days which appears sufficient to induce good tumour regression.
The treatment is planned by establishing a radiation field (usually 5 x 5 cm in the early tumour) which, entering at a point 1 cm above and 1 cm behind the external auditory meatus, exits at the opposite angle of the mouth. A cellulose acetate beam-direction shell is used and the selected field is checked by radiograph to show the avoidance of the midbrain and contralateral eye. By taking a contour from the-shell it is possible to add a second field of radiation using 600 wedges to confine the high-dose volume to the petrous-temporal bone, avoiding the midbrain and pituitary area.
In more advanced tumours, where extension has occurred beyond the limits of the petrous-temporal bone, larger fields and more simple techniques are indicated. This is well illustrated by one patient in whom before radiotherapy the tumour extended into the left occipital condyle and was destroying the arch of the first cervical vertebra. Treatment consisted of an 1 x 8 cm parallel pair of fields treating through the head to a dose of 4250 rad in 11 days. Bone healing occurred at three years and the patient remains well 7j years after treatment.
Conclusions
Megavoltage irradiation is the treatment of choice for tumours of the glomus jugulare. It is essential to avoid vital brain tissues during treatment but where this is not possible tumour doses should be kept within tolerance levels. A dose of 4500 rad in three weeks is sufficient to produce resolution of tumour. Surgery will probably also be successful in the earlier tumours but is best held in reserve until failure of radiotherapy is clearly apparent.
